Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roquefort Investments PLC (GB:ROQ)
LSE:ROQ
Holding GB:ROQ?
Track your performance easily
ROQ Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range3.30p - 9.50p
Previous Close4.5p
Volume1.02M
Average Volume (3M)1.31M
Market Cap
£6.11M
Enterprise Value5.57M
Total Cash (Recent Filing)£537.32K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta-0.17
Next Earnings
May 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding129,149,998
10 Day Avg. Volume1,599,498
30 Day Avg. Volume1,307,316
Standard Deviation0.17
R-Squared0.00811
Alpha0.00091
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)112.50
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Roquefort Investments PLC News
PremiumCompany Announcements
Roquefort Therapeutics Proposes Sale of Lyramid to Pleiades Pharma
PremiumCompany Announcements
Roquefort Therapeutics Boosts Director Stake with Share Distribution
PremiumCompany Announcements
Roquefort Therapeutics Converts Loan Notes to Bolster Growth
PremiumCompany Announcements
Roquefort Therapeutics Showcases Promising STAT-6 siRNA Results
PremiumCompany Announcements
Roquefort Therapeutics Strikes $10M Licensing Deal
PremiumCompany Announcements
Roquefort Therapeutics Secures Japanese Patent
PremiumCompany Announcements
Roquefort Therapeutics’ Breakthrough in siRNA TherapyPremiumCompany Announcements
Roquefort Therapeutics Secures Key European PatentOptions Prices
Currently, No data available
---
Ownership Overview
ROQ FAQ
What was Roquefort Investments PLC’s price range in the past 12 months?
Roquefort Investments PLC lowest share price was 3.30p and its highest was 9.50p in the past 12 months.
What is Roquefort Investments PLC’s market cap?
Currently, no data Available
When is Roquefort Investments PLC’s upcoming earnings report date?
Roquefort Investments PLC’s upcoming earnings report date is May 07, 2025 which is in 119 days.
How were Roquefort Investments PLC’s earnings last quarter?
Roquefort Investments PLC released its earnings results on Sep 27, 2024. The company reported -0.004p earnings per share for the quarter, missing the consensus estimate of N/A by -0.004p.
Is Roquefort Investments PLC overvalued?
According to Wall Street analysts Roquefort Investments PLC’s price is currently Overvalued.
Does Roquefort Investments PLC pay dividends?
Roquefort Investments PLC does not currently pay dividends.
What is Roquefort Investments PLC’s EPS estimate?
Roquefort Investments PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Roquefort Investments PLC have?
Roquefort Investments PLC has 135,736,600 shares outstanding.
What happened to Roquefort Investments PLC’s price movement after its last earnings report?
Roquefort Investments PLC reported an EPS of -0.004p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Roquefort Investments PLC?
Currently, no hedge funds are holding shares in GB:ROQ
---
Company Description
Roquefort Investments PLC
Roquefort Investments PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses that are at an early stage in the medical sector including Drug and vaccine development; Diagnostics; Immuno-therapy; and Cell and gene therapies.
---
Technical Analysis
---